Hypoxia, HIF1 and glucose metabolism in the solid tumour
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated HIF-1 plays a crucial role in adaptive responses of the tumor cells to changes in oxygen through transcriptional activation of over 100 downstream genes which regulate vital biological processes required for tumor survival and progression.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1 mediates this metabolic conversion through the induction of enzymes involved in the glycolysis pathway and overexpression of glucose transporters (GLUTs) which increase glucose import into tumor cells3.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1α is activated due to blockade of its degradation pathway mediated by low oxygen levels, thereby increasing the expression of target genes, including those encoding glycolytic enzymes and glucose transporters, and increasing lactate secretion67.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [67]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
Background
Cited by
Items 501–600 of 1,002
Natural Compounds as Regulators of the Cancer Cell Metabolism
Cerella, C., Radogna, F., Dicato, M. A., & Diederich, M. F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/639401 · Cited by 68
Hypothesis: Using the Warburg effect against cancer by reducing glucose and providing lactate
Nijsten, M. W., & van Dam, G. M. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.01.041 · Cited by 66
Rasmussen, L. M., Frederiksen, K. S., Din, N., Galsgaard, E. D., Christensen, L., Berchtold, M. W., & Panina, S. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0326 · Cited by 70
Pheochromocytoma: The First Metabolic Endocrine Cancer
Jochmanová, I., & Pacák, K. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0606 · Cited by 70
Chen, Z., Tian, D., Liao, X., Zhang, Y., Xiao, J., Chen, W., Liu, Q., Chen, Y., Li, D., Zhu, L., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00260 · Cited by 67
Müller, M. J., Gerndt, S., Chao, Y., Zisis, T., Nguyen, O. N. P., Gerwien, A., Urban, N. D., Müller, C., Gegenfurtner, F. A., Geisslinger, F., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.023 · Cited by 72
Defining the role of oxygen tension in human neural progenitor fate
Xie, Y., Zhang, J., Lin, Y., Gaeta, X., Meng, X., Wisidagama, D. R. R., Cinkornpumin, J., Koehler, C. M., Malone, C. S., Teitell, M. A., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.09.021 · Cited by 65
“HIFs are major regulators of the cellular response to O2 tension (Denko, 2008; Lendahl et al., 2009; Majmundar et al., 2010).”
BackgroundLi, X., Wang, M., Li, S., Chen, Y., Wang, M., Wu, Z., Sun, X., Yao, L., Dong, H., Song, Y., et al. (2021) · Theranostics · doi:10.7150/thno.57804 · Cited by 73
Ghosh, R., Samanta, P., Sarkar, R., Biswas, S., Saha, P., Hajra, S., & Bhowmik, A. (2022) · Molecules · doi:10.3390/molecules27165192 · Cited by 248
Liu, T., Han, S., Yao, Y., & Zhang, G. (2023) · Cancer Management and Research · doi:10.2147/cmar.s421771 · Cited by 69
Xu, F., Wang, M., Dotse, E., Chow, K. T., & Lo, P. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202404561 · Cited by 75
Kumar, A., Kant, S., & Singh, S. M. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.06.005 · Cited by 67
The role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 76
Wartenberg, M., Richter, M., Datchev, A., Guenther, S., Milosevic, N., Bekhite, M. M., Figulla, H., Aran, J. M., Pétriz, J., & Sauer, H. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22422 · Cited by 72
Oxygen-sensing by arterial chemoreceptors: Mechanisms and medical translation
López‐Barneo, J., Ortega‐Sáenz, P., González‐Rodríguez, P., Fernández-Agüera, M. C., Macías, D., Pardal, R., & Gao, L. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.002 · Cited by 70
Golias, T., Papandreou, I., Sun, R. C., Kumar, B., Brown, N. V., Swanson, B. J., Pai, R. K., Jaitin, D. A., Le, Q., Teknos, T. N., et al. (2016) · Scientific Reports · doi:10.1038/srep31146 · Cited by 69
Self-citationLeung, E., Cairns, R. A., Chaudary, N., Vellanki, R. N., Kalliomäki, T., Moriyama, E. H., Mujčić, H., Wilson, B. C., Wouters, B. G., Hill, R. P., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3402-6 · Cited by 70
RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma
Houles, T., Gravel, S.-P., Lavoie, G., Shin, S., Savall, M., Méant, A., Grondin, B., Gaboury, L., Yoon, S.-O., St-Pierre, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2215 · Cited by 64
HIF-1α is a Prognostic Marker in Oral Squamous Cell Carcinomas
Eckert, A. W., Schütze, A., Lautner, M. H. W., Taubert, H. W., Schubert, J., & Bilkenroth, U. (2010) · The International Journal of Biological Markers · doi:10.1177/172460081002500205 · Cited by 66
Yang, Y., Zhang, G., Guo, F., Li, Q., Luo, H. B., Shu, Y., Shen, Y., Gan, J., Xu, L., & Yang, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108340 · Cited by 67
pH responsive fluorescence nanoprobe imaging of tumors by sensing the acidic microenvironment
Wang, L., & Li, C. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm12072g · Cited by 64
Hypoxia-Inducible Factor 1 Regulation through Cross Talk between mTOR and MT1-MMP
Sakamoto, T., Weng, J. S., Hara, T., Yoshino, S., Kozuka‐Hata, H., Oyama, M., & Seiki, M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01169-13 · Cited by 68
Peppicelli, S., Toti, A., Giannoni, E., Bianchini, F., Margheri, F., Rosso, M. D., & Calorini, L. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191706 · Cited by 67
Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment
Elkashef, S. M., Allison, S. J., Sadiq, M., Basheer, H. A., Morais, G. R., Loadman, P. M., Pors, K., & Falconer, R. A. (2016) · Scientific Reports · doi:10.1038/srep33026 · Cited by 66
Mitochondrial uncoupling in cancer cells: Liabilities and opportunities
Baffy, G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.005 · Cited by 69
Jha, N. K., Jha, S. K., Sharma, R., Kumar, D., Ambasta, R. K., & Kumar, P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170589 · Cited by 61
Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
Korga-Plewko, A., Ostrowska-Leśko, M., Józefczyk, A., Iwan, M., Wojcik, R., Zgórka, G., Herbet, M., Vilarrubla, G. G., & Dudka, J. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-019-0301-2 · Cited by 64
Tolonen, J.-P., Heikkilä, M., Malinen, M., Lee, H.-M., Palvimo, J. J., Wei, G.-H., & Myllyharju, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03387-9 · Cited by 63
Ma, J., Zhang, Q. H., Chen, S., Fang, B., Yang, Q., Chen, C., Miele, L., Sarkar, F. H., Xia, J., & Wang, Z. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069485 · Cited by 71
RetractedMelanoma: A model for testing new agents in combination therapies
Ascierto, P. A., STREICHER, H. Z., & Sznol, M. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-38 · Cited by 65
Altemus, M., Goo, L., Little, A. C., Yates, J. A., Cheriyan, H., Wu, Z.-F., & Merajver, S. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220973 · Cited by 64
Anticancer effects of acteoside: Mechanistic insights and therapeutic status
Khan, R. A., Hossain, R., Roy, P., Jain, D., Saikat, A. S. M., Shuvo, A. P. R., Akram, M., Elbossaty, W. F., Khan, I. N., Painuli, S., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174699 · Cited by 63
Icard, P., Simula, L., Fournel, L., Leroy, K., Mansuet‐Lupo, A., Damotte, D., Charpentier, M.-C., Durdux, C., Loi, M., Schussler, O., et al. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100852 · Cited by 68
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer
Park, S. J., Yoo, H. C., Ahn, E., Luo, E., Kim, Y., Sung, Y., Yu, Y. C., Kim, K., Min, D. S., Lee, H. S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2045 · Cited by 65
Lozier, A., Rich, M. E., Grawe, A. P., Peck, A. S., Zhao, P., Chang, A., Bond, J. P., & Sholler, G. L. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2768 · Cited by 64
Molecular mechanisms regulating macrophage response to hypoxia
Rahat, M. A. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00045 · Cited by 62
Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells
Jiang, Y., Zhu, Y. J., Wang, X., Gong, J., Hu, C., Guo, B., Zhu, B., & Li, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3352 · Cited by 66
Warburg effect in Gynecologic cancers
Kobayashi, Y., Banno, K., Kunitomi, H., Takahashi, T., Takeda, T., Nakamura, K., Tsuji, K., Tominaga, E., & Aoki, D. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13867 · Cited by 66
The roles and role-players in thyroid cancer angiogenesis
Rajabi, S., Dehghan, M. H., Dastmalchi, R., Mashayekhi, F. J., Salami, S., & Hedayati, M. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0537 · Cited by 68
Glucose metabolic phenotype of pancreatic cancer
Chan, A. K. C., Bruce, J. I. E., & Siriwardena, A. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i12.3471 · Cited by 64
Liang, Y., Zhang, D., Zheng, T., Yang, G., Wang, J., Meng, F., Liu, Y., Zhang, G., Zhang, L., Han, J., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0242-z · Cited by 69
Chen, D., Zhang, Y., Wang, W., Chen, H., Ling, T., Yang, R., Wang, Y., Duan, C., Liu, Y., Guo, X., et al. (2021) · Advanced Science · doi:10.1002/advs.202100311 · Cited by 71
Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments
Kennedy, P. R., Arvindam, U. S., Phung, S. K., Ettestad, B., Feng, X., Li, Y., Kile, Q. M., Hinderlie, P., Khaw, M. J., Huang, R., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn1849 · Cited by 73
Inducible Metabolic Adaptation Promotes Mesenchymal Stem Cell Therapy for Ischemia
Zhu, H., Sun, A., Zou, Y., & Ge, J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303194 · Cited by 62
Li, P., Wu, M., Wang, J., Sui, Y., Liu, S., & Shi, D. (2015) · Redox Biology · doi:10.1016/j.redox.2015.12.001 · Cited by 65
Giedt, R. J., Feruglio, P. F., Pathania, D., Yang, K. S., Kilcoyne, A., Vinegoni, C., Mitchison, T. J., & Weissleder, R. (2016) · Scientific Reports · doi:10.1038/srep32985 · Cited by 62
Gao, R., Buechel, D., Kalathur, R. K. R., Morini, M. F., Coto‐Llerena, M., Ercan, C., Piscuoglio, S., Chen, Q., Blumer, T., Wang, X., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00338-7 · Cited by 64
The Relationship between Circadian Rhythm and Cancer Disease
Munteanu, C., Turti, S., Achim, L., Muresan, R., Souca, M., Prifti, E., Mârza, S. M., & Papuc, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115846 · Cited by 76
Zhao, W., Chang, C., Cui, Y., Zhao, X., Yang, J., Shen, L., Zhou, J., Hou, Z., Zhang, Z., Ye, C., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.535989 · Cited by 61
The Hypoxic Tumor Microenvironment: Driving the Tumorigenesis of Non-Small-Cell Lung Cancer
Foster, J. G., Wong, S. C. K., & Sharp, T. V. (2014) · Future Oncology · doi:10.2217/fon.14.201 · Cited by 68
Knudsen, E. S., Balaji, U., Freinkman, E., McCue, P. A., & Witkiewicz, A. K. (2016) · Oncotarget · doi:10.18632/oncotarget.11893 · Cited by 64
Synaptic activity‐induced glycolysis facilitates membrane lipid provision and neurite outgrowth
Segarra‐Mondejar, M., Casellas‐Díaz, S., Ramiro‐Pareta, M., Müller‐Sánchez, C., Riera, A. M., Hermelo, I., Reina, M., Aragonés, J., Martínez-Estrada, O. M., & Soriano, F. X. (2018) · The EMBO Journal · doi:10.15252/embj.201797368 · Cited by 72
Guan, X., Hasan, M. N., Begum, G., Kohanbash, G., Carney, K. E., Pigott, V. M., Persson, A. I., Castro, M. G., Jia, W., & Sun, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1062-3 · Cited by 63
Niu, D., Luo, T. L., Wang, H., Xia, Y., & Xie, Z. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.08.011 · Cited by 62
Sun, L., Gao, W., Liu, J., Wang, J., Li, L., Yu, H., & Xu, Z. P. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c18960 · Cited by 60
Kumar, S., Donti, T., Agnihotri, N., & Mehta, K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28623 · Cited by 64
Availability, not respiratory capacity governs oxygen consumption of solid tumors
Vaupel, P. W., & Mayer, A. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.019 · Cited by 64
Mao, L., Chen, Q., Gong, K., Xu, X., Xie, Y., Zhang, W., Cao, H., Hu, T., Hong, X., & Zhan, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6318 · Cited by 59
One‐Pot Approach to Fe2+/Fe3+‐Based MOFs with Enhanced Catalytic Activity for Fenton Reaction
Meng, X., Zhang, F., Guo, H., Zhang, C., Hu, H., Wang, W., Liu, J., Shuai, X., & Cao, Z. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100780 · Cited by 59
Hu, Q., Qin, Y., Ji, S., Shi, X., Dai, W., Fan, G., Li, S., Xu, W., Liu, W., Liu, M., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-0414 · Cited by 63
Recent advances in mitochondria‐targeting theranostic agents
Qian, K., Gao, S., Jiang, Z., Ding, Q., & Cheng, Z. (2024) · Exploration · doi:10.1002/exp.20230063 · Cited by 74
Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression
Peppicelli, S., Bianchini, F., Toti, A., Laurenzana, A., Fibbi, G., & Calorini, L. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1078032 · Cited by 68
Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours
Boeuf, S., Bovée, J. V. M. G., Lehner, B., Hogendoorn, P. C. W., & Richter, W. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03528.x · Cited by 61
Mitochondrial pyruvate carrier function and cancer metabolism
Rauckhorst, A. J., & Taylor, E. B. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.05.003 · Cited by 60
The hypoxia-inducible factor (HIF) couples immunity with metabolism
Halligan, D. N., Murphy, S. J. E., & Taylor, C. T. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.09.004 · Cited by 63
Zhou, F., Du, J. T., & Wang, J. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2927-3 · Cited by 62
Physiological functions of FBW7 in cancer and metabolism
Shimizu, K., Nihira, N. T., Inuzuka, H., & Wei, W. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.02.009 · Cited by 61
Eckert, A. W., Lautner, M. H. W., Schütze, A., Bolte, K., Bache, M., Kappler, M., Schubert, J., Taubert, H. W., & Bilkenroth, U. (2009) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2009.00829.x · Cited by 66
Bhalla, K., Jaber, S. M., Nanaji, N. M., Underwood, K. F., Beheshti, A., Landon, A. L., Bhandary, B., Bastian, P., Evens, A. M., Haley, J. D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19182-8 · Cited by 67
HPV – Das andere Kopf-Hals-Karzinom
Wittekindt, C., Wagner, S., Sharma, S. J., Würdemann, N., Knuth, J., Reder, H., & Klußmann, J. P. (2018) · Laryngo-Rhino-Otologie · doi:10.1055/s-0043-121596 · Cited by 83
Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts
Hyun, D. (2020) · Cancers · doi:10.3390/cancers12071822 · Cited by 61
Metabolism and immunity in breast cancer
Zhang, D., Xu, X., & Ye, Q. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0793-6 · Cited by 63
Wang, P., Yan, Q., Liao, B., Zhao, L., Xiong, S., Wang, J., Zou, D., Pan, J., Wu, L., Deng, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03150-0 · Cited by 60
Tojo, K., Tamada, N., Nagamine, Y., Yazawa, T., Ota, S., & Goto, T. (2017) · The FASEB Journal · doi:10.1096/fj.201700888r · Cited by 60
Safley, S. A., Kenyon, N. S., Berman, D. M., Barber, G. F., Willman, M. A., Duncanson, S., Iwakoshi, N. N., Holdcraft, R. W., Gazda, L. S., THOMPSON, P. W., et al. (2018) · Xenotransplantation · doi:10.1111/xen.12450 · Cited by 57
Ciou, T.-Y., Korupalli, C., Chou, T., Hsiao, C.-H., Getachew, G., Bela, S., & Chang, J. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00452 · Cited by 59
Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer
Ganji, C., Muppala, V., Khan, M., Nagaraju, G. P., & Farran, B. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103469 · Cited by 58
Spatial Reorganization of Saccharomyces cerevisiae Enolase To Alter Carbon Metabolism under Hypoxia
Miura, N., Shinohara, M., Tatsukami, Y., Sato, Y., Morisaka, H., Kuroda, K., & Ueda, M. (2013) · Eukaryotic Cell · doi:10.1128/ec.00093-13 · Cited by 62
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective
Ahmad, J., Akhter, S., Khan, M. A., Wahajuddin, M., Greig, N. H., Kamal, M. A., Midoux, P., & Pichon, C. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160617112111 · Cited by 61
ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α
Lee, J. H., Hur, W., Hong, S. W., Kim, J., Kim, S., Lee, E. B., & Yoon, S. K. (2016) · Oncology Reports · doi:10.3892/or.2016.5293 · Cited by 57
Metabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症:英文版 · doi:10.1002/cac2.12182 · Cited by 62
Role of FDG‐PET as a biological marker for predicting the hypoxic status of tongue cancer
Han, M. W., Lee, H. J., Cho, K., Kim, J. S., Roh, J., Choi, S., Nam, S. Y., & Kim, S. Y. (2011) · Head & Neck · doi:10.1002/hed.21945 · Cited by 57
Oxygen Sensing, Homeostasis, and Disease
Bels, D. D., Corazza, F., & Balestra, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1110602
The role of tumor microenvironment on cancer stem cell fate in solid tumors
Razi, S., Haghparast, A., Khameneh, S. C., Sadrabadi, A. E., Aziziyan, F., Bakhtiyari, M., Nabi‐Afjadi, M., Tarhriz, V., Jalili, A., & Zalpoor, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01129-w · Cited by 59
Cancer Stem Cells Under Hypoxia as a Chemoresistance Factor in the Breast and Brain
Crowder, S. W., Balikov, D. A., Hwang, Y., & Sung, H. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-013-0035-6 · Cited by 59
Boso, D., Rampazzo, E., Zanon, C., Bresolin, S., Maule, F., Porcù, E., Cani, A., Puppa, A. D., Trentin, L., Basso, G., et al. (2019) · Theranostics · doi:10.7150/thno.35882 · Cited by 59
Michl, J., Wang, Y., Monterisi, S., Błaszczak, W., Beveridge, R. D. D., Bridges, E., Koth, J., Bodmer, W. F., & Swietach, P. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110493 · Cited by 60
Fu, L., Qi, C., Sun, T., Huang, K., Lin, J., & Huang, P. (2023) · Exploration · doi:10.1002/exp.20210110 · Cited by 58
Hypoxia in cervical cancer: from biology to imaging
Lyng, H., & Malinen, E. (2017) · Clinical and Translational Imaging · doi:10.1007/s40336-017-0238-7 · Cited by 55
Modulation of glutathione promotes apoptosis in triple‐negative breast cancer cells
Vogg, A. T. J., Drude, N., Mottaghy, F. M., Morgenroth, A., & Miran, T. (2018) · The FASEB Journal · doi:10.1096/fj.201701157r · Cited by 56
Shen, L., Li, H., Bin, S., Li, P., Chen, J., Gu, H., & Yuan, W. (2019) · Oncology Reports · doi:10.3892/or.2019.7263 · Cited by 55
Hong, X., Zhong, L., Xie, Y., Zheng, K., Pang, J., Li, Y., Yang, Y., Xu, X., Mi, P., Cao, H., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01437 · Cited by 60
R�os, S., Wright, A. J., D’Santos, P., Hu, D., Hesketh, R. L., Lubling, Y., Georgopoulou, D., Lerda, G., Couturier, D., Razavi, P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.016 · Cited by 55
Gao, Y., Kim, S., Lee, Y., & Lee, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225601 · Cited by 57
The role of connexin43–Src interaction in astrocytomas: A molecular puzzle
Tabernero, A., Gangoso, E., Jaraíz-Rodríguez, M., & Medina, J. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.029 · Cited by 59
Wei, W., Shin, Y. S., Ma, C., Wang, J., Elitaş, M., Fan, R., & Heath, J. R. (2013) · Genome Medicine · doi:10.1186/gm479 · Cited by 58
Al-Akra, L., Bae, D.-H., Sahni, S., Huang, M. L. H., Park, K. C., Lane, D. J. R., Jansson, P. J., & Richardson, D. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772699 · Cited by 54
Love, N. R., Ziegler, M., Chen, Y., & Amaya, E. (2013) · BioEssays · doi:10.1002/bies.201300110 · Cited by 58
Zhang, Z., Fan, J., Du, J., & Peng, X. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213575 · Cited by 53
The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy
Chen, F., Xue, Y., Zhang, W., Zhou, H., Zhou, Z., Chen, T., Yinwang, E., Li, H., Ye, Z., Gao, J., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10211-9 · Cited by 58
Metadata
- Authors
- Denko, N. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Denko, Nicholas C.
- ORCID
- Denko, Nicholas C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-14
- Volume
- 8
- Issue
- 9
- Pages
- 705-713
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066379425
- Cited by
- 1,707
- References
- 126
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 93 · 2023: 113 · 2022: 141 · 2021: 149 · 2020: 115 · 2019: 120 · 2018: 126 · 2017: 94 · 2016: 115 · 2015: 78 · 2014: 95 · 2013: 79 · 2012: 77
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA067166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia, HIF-1, glucose metabolism, solid tumors, aerobic glycolysis, Warburg effect, cancer metabolism, mitochondrial activity, tumor growth
- MeSH terms
- Cell Division, Glucose, Glycolysis, Humans, Mitochondria, Models, Biological, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.